Leadership & Pay ·
Edesa Biotech raises CEO salary to $657K and boosts other exec pay retroactive to July
EDSAEdesa Biotech, Inc.
The Board approved increases in annual base salaries for three executive officers, effective retroactively from July 1, 2026. Dr. Pardeep Nijhawan's compensation rises to $657,423, up from $357,696; Dr. Michael Brooks' salary increases to $591,681 from $335,340; and Peter Weiler's pay goes to $525,938 from $300,000. These adjustments follow the last change in 2023 and remain subject to existing employment agreements, including Dr. Nijhawan's arrangement where 90% of cash salary is issued as restricted share units. Edesa Biotech operates in the biotechnology sector, focusing on drug discovery and development.